Broadening the field of opportunity for medicinal chemists. Official journal of the European Federation for Medicinal Chemistry
Impact Factor 2.626 12 Issues per Year
Review Article

Metabolism-guided drug design

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
Neuroscience Medicinal Chemistry, Pfizer Worldwide Research and Development, 700 Main Street, Cambridge, USA
b
Cardiovascular, Metabolic and Endocrine Diseases Medicinal Chemistry, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, USA
c
Pharmacokinetics, Dynamics and Metabolism – New Chemical Entities, Pfizer Worldwide Research and Development, Cambridge, USA
E-mail: amit.kalgutkar@pfizer.com ;
Tel: +1 617 551 3336
Med. Chem. Commun., 2013,4, 631-652

DOI: 10.1039/C2MD20317K
Received 19 Oct 2012, Accepted 12 Dec 2012
First published online 17 Dec 2012

This article is part of themed collection: MedChemComm 2013 review articles
| | | | | | More
Please wait while Download options loads
Download Citation